A Biocompatible, Stimuli-Responsive, and Injectable Hydrogel with Triple Dynamic Bonds.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
03 Jul 2020
Historique:
received: 28 12 2019
revised: 25 06 2020
accepted: 01 07 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 27 3 2021
Statut: epublish

Résumé

Injectable hydrogels have attracted growing interests as promising biomaterials for clinical applications, due to their minimum invasive implanting approach and easy-handling performance. Nevertheless, natural biomaterials-based injectable hydrogels with desirable nontoxicity are suffering from limited functions, failing to fulfill the requirements of clinical biomaterials. The development of novel injectable biomaterials with a combination of biocompatibility and adequate functional properties is a growing urgency toward biomedical applications. In this contribution, we report a simple and effective approach to fabricate multi-functional CMC-OSA-DTP hydrogels. Two kinds of natural polysaccharide derived polymers, carboxymethyl chitosan (CMC) and oxidized alginate (OSA) along with 3,3'-dithiopropionic acid dihydrazide (DTP) were utilized to introduce three dynamic covalent bonds. Owing to the existence of triple dynamic bonds, this unique CMC-OSA-DTP hydrogel possessed smart redox and pH stimuli-responsive property, injectability as well as self-healing ability. In addition, the CCK-8 and live/dead assays demonstrated satisfying cytocompatibility of the CMC-OSA-DTP hydrogel in vitro. Based on its attractive properties, this easy-fabricated and multi-functional hydrogel demonstrated the great potential as an injectable biomaterial in a variety of biomedical applications.

Identifiants

pubmed: 32635318
pii: molecules25133050
doi: 10.3390/molecules25133050
pmc: PMC7412394
pii:
doi:

Substances chimiques

Alginates 0
Biocompatible Materials 0
Hydrogels 0
Polymers 0
Polysaccharides 0
carboxymethyl-chitosan 0
Chitosan 9012-76-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : U1733130; 11704244
Organisme : Natural Science Foundation of Shanghai
ID : 17ZR1441000
Organisme : Shanghai Science and Technology Innovation Action Plan
ID : 18511109000
Organisme : Basic Research Field of Shanghai Science and Technology Innovation Program
ID : 16JC1401500
Organisme : Medical-Engineering Cross research Funding of SJTU
ID : YG2017MS01; YG2016QN34

Références

ACS Appl Mater Interfaces. 2015 Jun 17;7(23):13029-37
pubmed: 26016388
Bone Res. 2017 May 30;5:17014
pubmed: 28584674
Pharmaceutics. 2019 Sep 19;11(9):
pubmed: 31546921
Molecules. 2019 Aug 19;24(16):
pubmed: 31430954
Nat Commun. 2019 May 14;10(1):2060
pubmed: 31089131
Biomacromolecules. 2014 Dec 8;15(12):4495-508
pubmed: 25279766
ACS Appl Mater Interfaces. 2016 Sep 14;8(36):23463-76
pubmed: 27541725
Molecules. 2019 Oct 25;24(21):
pubmed: 31731551
Biomacromolecules. 2014 May 12;15(5):1814-27
pubmed: 24684558
Acta Biomater. 2017 Aug;58:168-180
pubmed: 28583902
J Biomed Mater Res B Appl Biomater. 2016 Nov;104(8):1691-1702
pubmed: 26344054
Nat Commun. 2011 Oct 25;2:511
pubmed: 22027591
Nanomaterials (Basel). 2019 Apr 01;9(4):
pubmed: 30939729
Chem Commun (Camb). 2008 Nov 14;(42):5301-3
pubmed: 18985190
Acta Biomater. 2019 Sep 1;95:348-356
pubmed: 30831326
Adv Mater. 2015 Nov 25;27(44):7196-203
pubmed: 26499097
Molecules. 2019 Nov 29;24(23):
pubmed: 31795385
ACS Sens. 2017 Jan 27;2(1):151-156
pubmed: 28722424
Biomacromolecules. 2019 Apr 8;20(4):1478-1492
pubmed: 30843390
Biotechnol Prog. 2001 Sep-Oct;17(5):945-50
pubmed: 11587588
ACS Appl Mater Interfaces. 2017 Mar 22;9(11):9221-9225
pubmed: 28266838
Adv Mater. 2010 Aug 17;22(31):3463-83
pubmed: 20503208
Adv Mater. 2018 Mar;30(9):
pubmed: 29341264
Molecules. 2016 Nov 21;21(11):
pubmed: 27879635
ACS Appl Mater Interfaces. 2018 Feb 21;10(7):6180-6189
pubmed: 29380599
Carbohydr Polym. 2013 Apr 2;93(2):635-43
pubmed: 23499106
Adv Mater. 2019 Nov;31(48):e1904956
pubmed: 31608513
Biomacromolecules. 2011 Aug 8;12(8):2894-901
pubmed: 21699141
Adv Mater. 2013 Aug 14;25(30):4171-6
pubmed: 23765594
ACS Appl Mater Interfaces. 2018 Oct 3;10(39):33523-33531
pubmed: 30204399
J Mater Chem B. 2014 Mar 21;2(11):1584-1593
pubmed: 32261377
J Funct Biomater. 2019 Nov 14;10(4):
pubmed: 31739421
Biomacromolecules. 2016 Sep 12;17(9):2839-48
pubmed: 27519472
Chem Commun (Camb). 2016 Jan 18;52(5):978-81
pubmed: 26588349
Acta Biomater. 2014 Aug;10(8):3650-63
pubmed: 24811827
J Mater Chem B. 2018 Mar 7;6(9):1351-1358
pubmed: 32254420
Nat Mater. 2010 Feb;9(2):101-13
pubmed: 20094081
J Biomed Mater Res A. 2018 Apr;106(4):865-875
pubmed: 29314616
Int J Biol Macromol. 2016 Sep;90:44-52
pubmed: 26562551

Auteurs

Yujie Chen (Y)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Runjing Zhang (R)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Baiqin Zheng (B)

School of Pharmaceutical and Material Engineering, Jinhua Polytechnic, Jinhua, Zhejiang Province 321017, China.

Chao Cai (C)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Zhen Chen (Z)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Hua Li (H)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Hezhou Liu (H)

State Key lab of Metal Matrix composites, Shanghai Jiao Tong University, Shanghai 200240, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH